Skip to main content
. 2024 May 28;60(6):892. doi: 10.3390/medicina60060892

Table 1.

General summary of clinical trials on hesperidin as potential compound against SARS-CoV-2.

Reference Trial ID Year Study
Design
Study
Population
Duration Control Outcome Measures Results
[36] NCT04715932 2022 Randomized, double-blind, placebo-controlled 216 14 days Placebo Yes Yes
[37] NCT04452799 2020 Randomized double-blind 100 14 days No treatment Yes Yes
[38] IRCT20150725023332N5 2022 Randomized controlled 20 5 days No treatment Yes Yes